Evidence map›Paper›PMID 37221533›Full record

ArticleBMC public health2023

Spatio-temporal dynamic of the COVID-19 epidemic and the impact of imported cases in Rwanda.

Muhammed Semakula, François Niragire, Sabin Nsanzimana, Eric Remera, Christel Faes

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Evolution of COVID-19 dynamics in Guangdong Province, China: an endemic-epidemic modeling study.Archives of public health = Archives belges de sante publique · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhammed SemakulaI-BioStat, Hasselt University, Hasselt, Belgium. semakulam@gmail.com.
François NiragireDepartment of Applied Statistics, University of Rwanda, Kigali, Kigali, Rwanda.
Sabin NsanzimanaRwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Eric RemeraRwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Christel FaesI-BioStat, Hasselt University, Hasselt, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAfrica was threatened by the coronavirus disease 2019 (COVID-19) due to the limited health care infrastructure. Rwanda has consistently used non-pharmaceutical strategies, such as lockdown, curfew, and enforcement of prevention measures to control the spread of COVID-19. Despite the mitigation measures taken, the country has faced a series of outbreaks in 2020 and 2021. In this paper, we investigate the nature of epidemic phenomena in Rwanda and the impact of imported cases on the spread of COVID-19 using endemic-epidemic spatio-temporal models. Our study provides a framework for understanding the dynamics of the epidemic in Rwanda and monitoring its phenomena to inform public health decision-makers for timely and targeted interventions.

resultsThe findings provide insights into the effects of lockdown and imported infections in Rwanda's COVID-19 outbreaks. The findings showed that imported infections are dominated by locally transmitted cases. The high incidence was predominant in urban areas and at the borders of Rwanda with its neighboring countries. The inter-district spread of COVID-19 was very limited due to mitigation measures taken in Rwanda.

conclusionThe study recommends using evidence-based decisions in the management of epidemics and integrating statistical models in the analytics component of the health information system.

Indexed as

Communicable Diseases, ImportedCOVID-19EpidemicsCommunicable Disease ControlHumansRwandaCOVID-19EpidemiologySpatio-temporal models

Identifiers

PMID37221533
PMCPMC10203687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.